ISSN 0326-342 8
printed version 
ISSN 2346-8548
on-line version

Instructions to authors

• Scope and editorial policy
• Form and preparation of manuscripts
• Sending manuscripts

The Journal of Nephrology, Dialysis and Transplantation is intellectual property of the Federal Capital and Province of Buenos Aires Regional  Dialysis and Kidney Transplantation Association  as well as a scientific bulletin of the Buenos Aires Nephrology Association (ANBA). It is a quarterly publication which receives clinical or experimental paper-works related to nephrology, dialysis and transplantation. The articles to be published must be original and unpublished, although those ones that were announced  in scientific societies or published like abstracts can also be accepted. The Journal has adequated its indications for preparing manuscripts according to  requirements established by the International Commitee of Medical Journal Editor (ICMJE) in its latest publication (Ann Intern Med 1997, 126: 36-47) and its updating of May 2000, available in www.icmje.org

Manuscripts Submission:  Manuscripts will be sent by e-mail to the Journal Secretariat (ban@renal.org.ar). The first page of each paper should indicate (a) the title, informative but concise, (b) authors full name (first  name and then surname)  name of the Institutions where they work. (c) a brief title for header. (D) name and full address, phone number and e-mail address of the author who will correspond with the journal.
Applications for acceptance of works must be signed by all the authors, indicating the section where the manuscript should correspond to, and the assertion that the contents have not been published before.
Sections: Sections include Original Articles, Brief Communications, Revision Articles, Casuistry. Editorials, History of Nephrology, Letters to the Editor, Bibliographic Comments, Special Articles, Image in Nephrology, Technical Notes, Continuous Medical Education, Speciality News.
For the different kind of articles Spanish language shall be used preferently, otherwise English could be used with a summary in Spanish longer tan usual.
The articles will be prepared on a word procesor preferible with a recent Microsft version, on white sheet of paper 216 x279 mm (letter) or 210 x 297 mm (A4), with no less than 25 mm margin, witten only on one side of the page, double spaced, with letter type Times New Roman 12, Arial 10 or another with similar size. Pages must be numbered starting with the title.

Units of measurement: Metric system should be used. Hematological and clinical chemical measurements must be done according to The International Units System terms (SI) using decimal notation.

Abbreviations, Initials and Symbols : only standarized abbreviations will be used, avoiding them in Titles or abstracts. When using an abbrevation or initial for the first time the full term will preceed it, excepting standard measurement unit.

Original Works: They are empirical research Works with a máximum full-length of 4.000 words, excluding title, key words, bibliographic references, tables and figure legends. They will be divided into: Introduction, Materials and Methods,
Results and Discussion, as well as an abstract in Spanish preceded by the corresponding title, each new section will start on a new page.

Abstract: It will be placed right after the first page and must not exceed 250 words, avoiding the mentioning of tables and figures.
The abstract is independent from the article text. Its development is structured and consists of four paragraphs titled: “Introduction”, “Methods”, “Results”, “Conclusions”. At the end of same 3 to 6 key words in Spanish will be specified, selecting them from the terms included in the thesaurus list. DeCS – Descriptores en Ciencias de la Salud (http://decs.bvs.br//E//homepagee)

Introduction
The objectives of the work are declared,  and basis for study  and analysis are summarized. Results or conclusions must not be included.

Materials and Methods:
It includes a description of (a) selection of studied subjects and their characteristics,  (b) methods,
equipment and proceedings  Clinical studies must show details of the protocol (surveyed population, performed procedures, statistic basis. (c)  Guides or profesional ethics followed (see details later) (d) Fully detailed statistics methods must be shown, to enable its verification.

Results:
They must be shown in a logical sequence.. Information described on tables and figures, must not be repeated in the text.

Discussion:
New or important aspects of the study are emphasized as well as the conclusions obtained from them  and their relationship with the objectives mentioned in the Introduction. .Information already mentioned in other sections of the study should not be repeated. Priority declarations and references to non-completed studies must be avoided
Acnowledgments will be added when they correspond, prior to bibliography,  If it is needed acknowledgments for technical back-up, financial help and contributions, which do not justify authorship, will be quoted.  In these cases the authors will be responsible for obtaining written permission from  the persons involved.

Bibliography:Bibliography should be limited to those articles directly related to the study itself ,avoiding lengthy bibliographic revisions, only accepted in the Revision Articles. The quotes must follow uniformity requirements for Works of ICMJE available in http:/www.nlm.nih.gov/bsd/uniform_requirements.html.  References should be consecutively numbered, in the same order they are mentioned in the study. Six or less number of authors shall be included, if they are more than six, the sixth must be followed by the latin abbreviation et al (and others) The titles of the journals must be abbreviated according to the Medical Index style (the list could be obtained in www.nlm.nih.gov. The journals name must be witten in italics.  In the quotations texts they will be mentioned by their numbers on a superindex. On the list of references,articles, journals, books and book-chapters, scientific meeting minutes and available information on World Wide Web, should be mentioned according to the following examples:

1.Standard articles up to six authors (all authors are mentioned):
Halpern SD, Ubel PA, Caplan AL.Solid-organ transplantation in HIV-infected patients.
N Engl J Med.2002; 347:284-7

2. More than six authors (first six ones are mentioned followed by “et al”
Rose ME, Huerbin MB. Melick J, Marion DW, Palmer AM, Schiding JK, et al.Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury.Brain Res. 2002; 935:40-6

3. Books
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.…………………………………………………..

4. Books Chapters
Meltzer PS, Kallioniemi A, Trent JM, Chromosome alterations in human and solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cáncer. New York: McGraw-Hill; 2002. P. 93-113.

5. Conferences minutes
Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002

6. Web pages
Cancer-Pain org (Internet). New York: Association of Cancer Online Resources, Inc., c2000-01 (updated 2002 May 16; cited 2002 2002 Jul 9). Available from: http//www.cancer-pain.org/.

Articles references to be published will mention journal name and could only be quoted if they have already been accepted for their publication (press)
Personal communications are quoted on the text.

All references must be verified by the authors based on original documents, avoiding as much as posible quotations represented by communications or abstracts. Tables must be show on  single pages and listed with arabic numbers. They should be essential and understandable presenting a clearly explaining title.
Explanatory notes should be footnotes, and must not be included on the title.Separation vertical or horizontal lines between columns must not be used, except three in general: the ones separating titles from tables, headings from the rest, and the one that indicates the end of tables.
All figures (Drawings or black and white photographs) should permit an
adequate reproduction and will be consecutively numbered with an inscription at the back of the page, to enable identification and a figure legend on a separate page .Scale (marker) must be indicated when micro-photographs are shown. Besides, arrows, symbols or letters included, should present  sharp contrast with the background

Brief communications Empirical Works with  1.500 words full length correspond to results that although being preliminar  justify an early diffusion as articles of interest. Since the manuscript will not exceed eight pages, it should not be separated into sections,  keeping the usual sequence with up to 15 references and no more than two Tables or Figures. Publication of “ brief communications “ will be carried out within three months upon their acceptance.

Review Article:  6.000 words full length article, 6 tables or figures at most, and no more than 150 bibliographic references. A 250 words abstract will be included. They should involve up-to-date pertinent topics and must be backed up by a precise bibliography.

Casuistry:Corresponds to particular cases with new information and observations. They will be considered because of their clinical interest and not only due to their pecularity. They should be 1.500 words full length manuscript (eight pages) including up to two Tables and Figures and no more than 15 references.
Brief communications, review articles and Casuistry will include abstracts in Spanish or English (no more than 150 words) and a key words list.

Editorials: Could be required by the editor or proposed by the autor without prior invitation. They must consist of a maximum 1.500 words full length, without abstract, with one possible Table or Figure, and 30 bibliographic references at maximum. The opportunity and eventual characteristics of the editorials are exclusively carried out by the Editorial Commitee selection criteria.

Special Articles:Monographs, Articles or Translations of main importance or outstanding scientific advance that justify their diffusion to the nephrologists, and submitted to the Editorial Commitee exclusive decisión.

Letters to the Editorial Commitee: are referred to editorial  comments, preferably related to already published articles in the Journal. They must not exceed 3 pages, and 6 references and one Table or Figure could be included.

Image in Nephrology: In every case, each author must have participated deeply enough in the work to asume full reponsibility for its contents. When involving multicenter studies, the participants should appear as authors below the title or at the bottom of page. When this criteria do not correspond, they should be mentioned in acknowledgments.
Each manuscript that is received will be examined by the Editorial Commitee and usually also by one or two external revisers (who are not members of this Commitee) After the mentioned revisión, the responsible author is notified about the acceptance (with or without corrections and changes) or about the rejection of the manuscript. The Editorial Commitee reserves the right to introduce, with the authors aproval, all the editorial changes  according to gramar rules and for collating purposes.
A secondary publication could be effected, in the same or other language provided that the following conditions are observed: (1) the editors of the second publication must receive copy of the first one (2) The first publication priority will be respected within a less than  a week period (unless other conditions are accepted by both editors) (3) Usually secondary publication is a summarized or simplified version of the first one.  On the first page there must a footer referring to the original publication. Secondary version refflects the information given in the first one.
The Journal of Nephrology, Dialysis and Transplant follows the guidelines  set forth by the International Commitee of Medical Journal Editors, www.icmje.org about other subjects not mentioned here and also about conflict of interest involving copy editors, authors and editors, the relationship  with the industry, the financial help received from it, manuscripts confidentiality and the relationship between Journals and the media.
Ethical aspects : Whenever it corresponds, the article must mention that the informed consent has been fulfilled as well as the revision and approval of the study protocol , by  the Ethical Commitee of the Institution where the study was performed.
For all clinical experiments it must be informed that the Helsinski declaration was respected and comply with. This information must also be stated in Methods as well as the fullfillment of informed consent. For complete text :http://www.wma.net/en/30publicaciones/10policies/b3/.
For Transplant articles it must be informed that the Istanbul Declaration was respected and complied with and must be stated in Methods. For further information: http/www.declarationofistanbul.org/
For all animals experimentation described in the manuscript, it is required that the authors express their compliance with the NIH guideline for the Care and Use of Laboratory Animals or equivalent. It must be declared in Methods. For complete texts of the addresses: http:/grants.nih.gov/olaw/references/phsol.htm.
Authors Scientif Misconduct: as plagiarisms,  publications duplication, access to outside data, finding concealments,false data, conflict of interest false information, etc.,  could  result in  rejection of the manuscripts, prohibition of future submissions, report of misbehaviour to the Ethical Commitee, to the Institutions where the authors carry out tasks, to entities  which financially supported their work,  to Institutions that grant support to research,  and in  publishing  the situation in the Journal.
Authorship: it must be based on: 1) a substantial contribution to conception and design, or data acquisition, or analysis and interpretation of mentioned data, 2) article editing or critical revision of its intellectual  content, 3) final aproval of the version to be published.The authors should fulfill these conditions: http://www.icmje.org/ and www.icmje.org/
Conflict of Interest Declaration: All participants in the revision and publication process must disclose every relationship that could be regarded as potential conflic of interest. When presenting a manuscript, either an article or a letter, authors must reveal possible conflicts of interest. They are responsible of disclosing any financial relationship that could skew their work.Relationships with pharmaceutical enterprises or other entities (jobs, contracts, consulting commitees, spokespersons,member of steering commitee,  shareholders) that could be perceived as conflict of interest, must be informed, or the authors must declare that there is not any   financial conflict of interest. This declaration must be placed at the end of the text. Full form that could be obtained through: www.renal.org.ar/revista/informacion para autores., must be attached to the articles when being delivered.
Authorization for "reprint letters", granting permission letter for reprinting all printing material or adaptation must be also included..

 Trials: they must be registered in a clinical trials Public Register. The register date must be prior to patients enrollment. A "Trial" is any research project which prospectively assigns human subjects for interventions  or comparison groups to be surveyed between a medical intervention and a health outcome.Examples: www.clinicaltrials.gov  www.controlletrials.com www.cochranereenal.org/  trial submission form.php. -www.update-software.com/national/ - http:/eudract.emea.eu.int/

 Randomized Controlled Trials (RCT) authors are recommended to consider   "CONSORT" guidelines dispositions - www.consort-statement.org/.

Manuscripts will be sent by email to the Secretariat of the magazine (ban@renal.org.ar). The first page should include: (a) the title, concise but informative; (b) the full names of the authors (first name then last name) and the institutions in which they work; (c) a short title for running head; (d) the name and full address, telephone and email address of the author to whom correspondence should.